{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:15:15Z","timestamp":1778822115120,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.intimp.2026.116705","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T23:05:11Z","timestamp":1777935911000},"page":"116705","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Ebselen's role in overcoming cisplatin resistance in colorectal Cancer via SQSTM1 ubiquitination modulation"],"prefix":"10.1016","volume":"181","author":[{"given":"Binbin","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dengyong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhixiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shilong","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dajun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2026.116705_bb0005","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.16987","article-title":"Assessment of a staging system for sigmoid colon cancer based on tumor deposits and extramural venous invasion on computed tomography","volume":"2","author":"D\u2019Souza","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.intimp.2026.116705_bb0010","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/ags3.12653","article-title":"Oncological outcomes of Crohn\u2019s disease-associated cancers focusing on disease behavior","volume":"7","author":"Yamamoto","year":"2023","journal-title":"Ann. Gastroenterol. Surg."},{"key":"10.1016\/j.intimp.2026.116705_bb0015","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-32186-3","article-title":"NEIL3-mediated proteasomal degradation facilitates the repair of cisplatin-induced DNA damage in human cells","volume":"13","author":"Aliyaskarova","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2026.116705_bb0020","article-title":"Therapeutic prospects of polysaccharides for ovarian Cancer","volume":"9","author":"Wang","year":"2022","journal-title":"Front. Nutr."},{"key":"10.1016\/j.intimp.2026.116705_bb0025","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2022.5426","article-title":"GSTO1 confers drug resistance in HCT-116 colon cancer cells through an interaction with TNF\u03b1IP3\/A20","volume":"61","author":"Paul","year":"2022","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.intimp.2026.116705_bb0030","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.3390\/pharmaceutics13081232","article-title":"A tri-stimuli responsive (Maghemite\/PLGA)\/chitosan nanostructure with promising applications in lung Cancer","volume":"13","author":"Fern\u00e1ndez-\u00c1lvarez","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.intimp.2026.116705_bb0035","first-page":"1","article-title":"miR-3059-3p regulates glioblastoma Multiforme Radiosensitivity enhancement through the homologous recombination pathway of DNA repair","volume":"2022","author":"Cheng","year":"2022","journal-title":"J. Oncol."},{"key":"10.1016\/j.intimp.2026.116705_bb0040","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1136\/ijgc-2023-004483","article-title":"Identification of RAD51 foci in cancer-associated circulating cells of patients with high-grade serous ovarian cancer: association with treatment outcomes","volume":"33","author":"Alizzi","year":"2023","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.intimp.2026.116705_bb0045","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.2174\/0929867329666220801165849","article-title":"Synthesis and antioxidant properties of Organoselenium compounds","volume":"30","author":"Mamgain","year":"2023","journal-title":"CMC"},{"key":"10.1016\/j.intimp.2026.116705_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.114652","article-title":"A revised version of the Iwaoka\u2019s assay: application of hyphenated techniques","volume":"212","author":"Fiorito","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.intimp.2026.116705_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.941962","article-title":"Protein ubiquitination in T cell development","volume":"13","author":"Zhong","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116705_bb0060","first-page":"1","article-title":"YOD1 Deubiquitinates NEDD4 involved in the hippo signaling pathway","volume":"54","year":"2019","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.intimp.2026.116705_bb0065","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/15548627.2021.1908722","article-title":"Emerging views of OPTN (optineurin) function in the autophagic process associated with disease","volume":"18","author":"Qiu","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.intimp.2026.116705_bb0070","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.molcel.2021.01.009","article-title":"Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling","volume":"81","author":"Zellner","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.intimp.2026.116705_bb0075","doi-asserted-by":"crossref","DOI":"10.1007\/s12032-023-01953-7","article-title":"CAFs secrete CXCL12 to accelerate the progression and cisplatin resistance of colorectal cancer through promoting M2 polarization of macrophages","volume":"40","author":"Jiang","year":"2023","journal-title":"Med. Oncol."},{"key":"10.1016\/j.intimp.2026.116705_bb0080","doi-asserted-by":"crossref","first-page":"18418","DOI":"10.18632\/oncotarget.4099","article-title":"Ebselen inhibits QSOX1 enzymatic activity and suppresses invasion of pancreatic and renal cancer cell lines","volume":"6","author":"Hanavan","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.intimp.2026.116705_bb0085","doi-asserted-by":"crossref","first-page":"5518","DOI":"10.1158\/0008-5472.CAN-10-0646","article-title":"RG7204 (PLX4032), a selective BRAFV600E inhibitor, displays potent antitumor activity in preclinical melanoma models","volume":"70","author":"Yang","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2026.116705_bb0090","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007572","article-title":"SGN-B7H4V, an investigational vedotin ADC directed to the immune checkpoint ligand B7-H4, shows promising activity in preclinical models","volume":"11","author":"Gray","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.intimp.2026.116705_bb0095","article-title":"Refining colorectal cancer classification and clinical stratification through a single-cell atlas","volume":"23","author":"Khaliq","year":"2022","journal-title":"Genome Biol."},{"key":"10.1016\/j.intimp.2026.116705_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/imt2.70070","article-title":"The microbiome in cancer","volume":"4","author":"Lin","year":"2025","journal-title":"IMeta"},{"key":"10.1016\/j.intimp.2026.116705_bb0105","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-020-0111-4","article-title":"Silencing MYH9 blocks HBx-induced GSK3\u03b2 ubiquitination and degradation to inhibit tumor stemness in hepatocellular carcinoma","volume":"5","author":"Lin","year":"2020","journal-title":"Sig Transduct Target Ther."},{"key":"10.1016\/j.intimp.2026.116705_bb0110","doi-asserted-by":"crossref","first-page":"780","DOI":"10.3892\/ijo.2020.5097","article-title":"Dexamethasone inhibits stemness maintenance and enhances chemosensitivity of hepatocellular carcinoma stem cells by inducing deSUMOylation of HIF-1\u03b1 and Oct4","volume":"57","author":"Jiang","year":"2020","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.intimp.2026.116705_bb0115","doi-asserted-by":"crossref","first-page":"966","DOI":"10.2174\/0109298665265642231020043809","article-title":"MicroRNA3650 promotes gastric Cancer proliferation and Migrationthrough the PTEN\/PI3K-AKT-mTOR and hippo pathways","volume":"30","author":"Yang","year":"2023","journal-title":"PPL"},{"key":"10.1016\/j.intimp.2026.116705_bb0120","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nature23449","article-title":"cGAS surveillance of micronuclei links genome instability to innate immunity","volume":"548","author":"Mackenzie","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2026.116705_bb0125","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/mdr2.70006","article-title":"Heterogeneity of Intratumoral microbiota within the tumor microenvironment and relationship to tumor development","volume":"1","author":"Gao","year":"2025","journal-title":"Med Research."},{"key":"10.1016\/j.intimp.2026.116705_bb0130","doi-asserted-by":"crossref","DOI":"10.34133\/research.0723","article-title":"Natural killer cell immune checkpoints and their therapeutic targeting in Cancer treatment","volume":"8","author":"Lin","year":"2025","journal-title":"Research"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926005515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926005515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:57:19Z","timestamp":1778821039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926005515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":26,"alternative-id":["S1567576926005515"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116705","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ebselen's role in overcoming cisplatin resistance in colorectal Cancer via SQSTM1 ubiquitination modulation","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116705","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116705"}}